...but @walidgellad.bsky.social#CP3at10 2/2

@TimAndersonMD focuses on identifying strategies to⬆️care quality (esp. prescribing decisions) delivered for older adults with chronic conditions. Read a recent paper in @AGSJournal: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...#CP3at10 2/2

Bryant comes to @PittGIM with many awards and a fellowship from @harvardmed. His work focuses on evaluating policies that affect timing and effectiveness of treatment for opioid use disorder. Check out one of his papers in @JAM_ASAM: journals.lww.com/journaladdic...#CP3at10 2/2

Evaluation of Resident Physicians’ Knowledge of and... : Journal of Addiction Medicine

ion (ACGME) accredited Florida IM residency programs. We used an online survey to collect information about resident demographics, substance use curriculums, career interests, content knowledge about ...

Ravy brings a wealth of pharmacoepidemiology expertise to CP3 & is often willing to help mentor trainees. His new @NIDDKgov R01 will use cutting-edge data analysis to assess which 💊should be stopped after acute pancreatitis & which essential medications are safe. #CP3at10 2/2

Ted is a practicing addiction psychiatrist and researcher @PittPsychiatry. His current K23 from @NIDAnews will develop a new treatment to help patients discontinue benzodiazepines more safely. Read a related paper @JSATjournal here: www.sciencedirect.com/science/arti... #CP3at10 2/2

“It could potentially be dangerous... but nothing else has seemed to help me.”: Patient and clin...

Benzodiazepine use among patients receiving opioid agonist treatment (OAT) presents a conundrum: benzodiazepines increase overdose risk, yet can treat…

Terri is an expert at using real-world data to analyze health & economic outcomes. You may have seen her speak on treatment gaps in sickle cell disease. Terri is also a vital member of the planning committee for our annual Pharmacoequity Conference! #CP3at10 2/2

Aimee is rapidly becoming a well-known expert on low-value health care and deprescribing low-value, especially for older adults. Earlier this year, Aimee was elected for the @PittGeriMed Pepper Scholars Program! Look for more great things to come from Aimee! #CP3at10 2/2

Katie leads an @AHRQNews R01 examining drug shortages and an @NIDCR R01 to⬇️risky💊prescribing by dentists to kids. Katie's a prolific author - over 20 papers so far this year alone! Read one of her latest in @JAPhAJournal: www.japha.org/article/S154... #CP3at10 2/2

You may have seen Jing on📺or in @nytimes discussing insulin pricing. Jing currently leads an international clinical trial examining use of analogue insulin for youth in low resource settings: www.cp3.pitt.edu/human-vs-ana... #CP3at10

@TomRadomskiMD is also a Director at @PittICRE & active in @SocietyGIM leadership. His grants include a K23 from @NIHAging to evaluate use & cost of low-value health services. Check out one of his recent papers in @JournalGIM here: jamanetwork.com/journals/jam... #CP3at10 2/2